Nodal metastasis and recurrence in papillary thyroid microcarcinoma

Adolfo Pisanu, Alessandra Saba, Mauro Podda, Isabella Reccia, Alessandro Uccheddu

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Despite the majority of papillary thyroid microcarcinoma (PTMC) patients has benign clinical courses, some PTMCs have a clinical presentation similar to conventional papillary thyroid carcinoma (PTC). The aim of this study was to identify risk factors for lymph node metastasis at presentation and prognostic parameters influencing nodal recurrence in PTMC. From January 1998 to October 2013, 556 consecutive patients had a diagnosis of differentiated thyroid carcinoma in our surgical department. A total of 219 (39.4 %) patients who had a pathological diagnosis of PTMC represented the cohort for the current study. We carried out a retrospective cohort study to compare 24 PTMC patients with lymph node metastasis at diagnosis (N1) and 195 PTMC patients without lymph node involvement (N0). The comparison between groups involved evaluation of patients and tumor characteristics. A diameter >8 mm, the presence of multifocality, and extrathyroid invasion (T3) were independent risk factors for nodal involvement at presentation. The presence of T3 was the only independent prognostic parameter influencing nodal recurrence. Prognostic factors for N1 at presentation and for recurrence are pathological parameters, thus it is not possible before surgery to detect PTMC patients who are at risk. However, we believe that a full treatment protocol should be also indicated in the case of PTMC according to risk stratification and cancer stage as for the conventional counterpart of PTC.

Original languageEnglish
Pages (from-to)575-581
Number of pages7
JournalEndocrine
Volume48
Issue number2
DOIs
Publication statusPublished - 2015

Fingerprint

Neoplasm Metastasis
Recurrence
Lymph Nodes
Cohort Studies
Clinical Protocols
Papillary Thyroid Microcarcinoma
Thyroid Neoplasms
Neoplasms
Retrospective Studies
Papillary Thyroid cancer

Keywords

  • Lymph node metastasis
  • Lymph node recurrence
  • N1
  • Papillary thyroid microcarcinoma
  • Prognosis
  • PTMC

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Nodal metastasis and recurrence in papillary thyroid microcarcinoma. / Pisanu, Adolfo; Saba, Alessandra; Podda, Mauro; Reccia, Isabella; Uccheddu, Alessandro.

In: Endocrine, Vol. 48, No. 2, 2015, p. 575-581.

Research output: Contribution to journalArticle

Pisanu, A, Saba, A, Podda, M, Reccia, I & Uccheddu, A 2015, 'Nodal metastasis and recurrence in papillary thyroid microcarcinoma', Endocrine, vol. 48, no. 2, pp. 575-581. https://doi.org/10.1007/s12020-014-0350-7
Pisanu, Adolfo ; Saba, Alessandra ; Podda, Mauro ; Reccia, Isabella ; Uccheddu, Alessandro. / Nodal metastasis and recurrence in papillary thyroid microcarcinoma. In: Endocrine. 2015 ; Vol. 48, No. 2. pp. 575-581.
@article{ff50690e81b64a7094031903ae69a5e2,
title = "Nodal metastasis and recurrence in papillary thyroid microcarcinoma",
abstract = "Despite the majority of papillary thyroid microcarcinoma (PTMC) patients has benign clinical courses, some PTMCs have a clinical presentation similar to conventional papillary thyroid carcinoma (PTC). The aim of this study was to identify risk factors for lymph node metastasis at presentation and prognostic parameters influencing nodal recurrence in PTMC. From January 1998 to October 2013, 556 consecutive patients had a diagnosis of differentiated thyroid carcinoma in our surgical department. A total of 219 (39.4 {\%}) patients who had a pathological diagnosis of PTMC represented the cohort for the current study. We carried out a retrospective cohort study to compare 24 PTMC patients with lymph node metastasis at diagnosis (N1) and 195 PTMC patients without lymph node involvement (N0). The comparison between groups involved evaluation of patients and tumor characteristics. A diameter >8 mm, the presence of multifocality, and extrathyroid invasion (T3) were independent risk factors for nodal involvement at presentation. The presence of T3 was the only independent prognostic parameter influencing nodal recurrence. Prognostic factors for N1 at presentation and for recurrence are pathological parameters, thus it is not possible before surgery to detect PTMC patients who are at risk. However, we believe that a full treatment protocol should be also indicated in the case of PTMC according to risk stratification and cancer stage as for the conventional counterpart of PTC.",
keywords = "Lymph node metastasis, Lymph node recurrence, N1, Papillary thyroid microcarcinoma, Prognosis, PTMC",
author = "Adolfo Pisanu and Alessandra Saba and Mauro Podda and Isabella Reccia and Alessandro Uccheddu",
year = "2015",
doi = "10.1007/s12020-014-0350-7",
language = "English",
volume = "48",
pages = "575--581",
journal = "Endocrine",
issn = "1355-008X",
publisher = "Humana Press Inc.",
number = "2",

}

TY - JOUR

T1 - Nodal metastasis and recurrence in papillary thyroid microcarcinoma

AU - Pisanu, Adolfo

AU - Saba, Alessandra

AU - Podda, Mauro

AU - Reccia, Isabella

AU - Uccheddu, Alessandro

PY - 2015

Y1 - 2015

N2 - Despite the majority of papillary thyroid microcarcinoma (PTMC) patients has benign clinical courses, some PTMCs have a clinical presentation similar to conventional papillary thyroid carcinoma (PTC). The aim of this study was to identify risk factors for lymph node metastasis at presentation and prognostic parameters influencing nodal recurrence in PTMC. From January 1998 to October 2013, 556 consecutive patients had a diagnosis of differentiated thyroid carcinoma in our surgical department. A total of 219 (39.4 %) patients who had a pathological diagnosis of PTMC represented the cohort for the current study. We carried out a retrospective cohort study to compare 24 PTMC patients with lymph node metastasis at diagnosis (N1) and 195 PTMC patients without lymph node involvement (N0). The comparison between groups involved evaluation of patients and tumor characteristics. A diameter >8 mm, the presence of multifocality, and extrathyroid invasion (T3) were independent risk factors for nodal involvement at presentation. The presence of T3 was the only independent prognostic parameter influencing nodal recurrence. Prognostic factors for N1 at presentation and for recurrence are pathological parameters, thus it is not possible before surgery to detect PTMC patients who are at risk. However, we believe that a full treatment protocol should be also indicated in the case of PTMC according to risk stratification and cancer stage as for the conventional counterpart of PTC.

AB - Despite the majority of papillary thyroid microcarcinoma (PTMC) patients has benign clinical courses, some PTMCs have a clinical presentation similar to conventional papillary thyroid carcinoma (PTC). The aim of this study was to identify risk factors for lymph node metastasis at presentation and prognostic parameters influencing nodal recurrence in PTMC. From January 1998 to October 2013, 556 consecutive patients had a diagnosis of differentiated thyroid carcinoma in our surgical department. A total of 219 (39.4 %) patients who had a pathological diagnosis of PTMC represented the cohort for the current study. We carried out a retrospective cohort study to compare 24 PTMC patients with lymph node metastasis at diagnosis (N1) and 195 PTMC patients without lymph node involvement (N0). The comparison between groups involved evaluation of patients and tumor characteristics. A diameter >8 mm, the presence of multifocality, and extrathyroid invasion (T3) were independent risk factors for nodal involvement at presentation. The presence of T3 was the only independent prognostic parameter influencing nodal recurrence. Prognostic factors for N1 at presentation and for recurrence are pathological parameters, thus it is not possible before surgery to detect PTMC patients who are at risk. However, we believe that a full treatment protocol should be also indicated in the case of PTMC according to risk stratification and cancer stage as for the conventional counterpart of PTC.

KW - Lymph node metastasis

KW - Lymph node recurrence

KW - N1

KW - Papillary thyroid microcarcinoma

KW - Prognosis

KW - PTMC

UR - http://www.scopus.com/inward/record.url?scp=84938320020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938320020&partnerID=8YFLogxK

U2 - 10.1007/s12020-014-0350-7

DO - 10.1007/s12020-014-0350-7

M3 - Article

C2 - 25007850

AN - SCOPUS:84938320020

VL - 48

SP - 575

EP - 581

JO - Endocrine

JF - Endocrine

SN - 1355-008X

IS - 2

ER -